Study of the Prevalence of Painful Symptoms of the Musculoskeletal System After Lung Transplantation

NCT03636802 | Unknown

• 1 other identifier: 2017-48
• Study Type: observational
• Target: 62
• Locations: 1 country
• Sites: 1

Brief Summary

Pulmonary transplantation (PT) is a therapeutic option now accepted in the management of selected patients who have reached the irreversible and terminal stage of their chronic respiratory insufficiency. Its main indications are: cystic fibrosis and other bronchial diseases, emphysema , interstitial lung diseases with idiopathic pulmonary fibrosis in the foreground, and severe pulmonary hypertension. The evocation of osteo-articular and musculotendinous pain symptoms in the aftermath of PT is frequent and very diversified. These complications are poorly codified and hinder the rehabilitation and early resumption of physical activity and sports. Few data are available on this subject in the literature. Following transplantation, improvements in respiratory function, quality of life, and exercise capacity are observed, with large inter-individual variations; Patients are encouraged to resume physical activity, initially as part of a rehabilitation exercise. Among the factors limiting exercise, some have been more widely studied, such as muscular deconditioning related to pre-existing chronic respiratory insufficiency , prolonged stay in intensive care, side effects of transplant-related treatments (corticosteroids and immunosuppressants). Pain is also a factor limiting the recovery of physical activity and quality of life. Pain related directly to thoracotomy surgery has been explored but there is little data available on musculoskeletal pain. The purpose of this study is to better understand the musculoskeletal pain occurring in the aftermath of a lung transplantation. Conducting this study for a period of 1 year will allow you to move away from the immediate post-transplant time, and the pain associated with the transplant will no longer have any interference. The main objective of our study is to better know the prevalence of algic manifestations of the musculoskeletal system (osteo-articular, musculotendinous ...) occurring in the year following a TP, and may constitute a brake on the rehabilitation of the musculoskeletal system. effort and recovery of physical activity or sport.

Conditions

Respiratory Insufficiency

Outcome Measures

Primary Outcomes (1)

• numbers of patients with symptoms of the musculoskeletal system

  numbers of patients presenting symptoms of the musculoskeletal system during the study

  1 years

Study Arms (1)

EXPERIMENTAL GROUP

Patient with respiratory failure and on a lung transplant waiting list

Other: Questionnaire BPI

Interventions

Questionnaire BPI OTHER

Brief Pain Inventory (BPI) This is a scale of self-assessment, the Concise Pain Questionnaire in French. For all adult patients For any type of pain This is to ask the patient to answer questions in order to learn about us characteristics of his pain (its intensity and its repercussions on the plane biopsychosocial).

EXPERIMENTAL GROUP

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patient registered on the lung transplant waiting list of the CHU de Marseille

You may qualify if:

• Patient over 18
• Having agreed to no opposition
• Registered on the lung transplant waiting list of the CHU de Marseille
• Able to read, understand and complete the self-questionnaires of the study

You may not qualify if:

• Patient under 18 years
• Patient refusing follow up until 12 months post transplant
• Pregnant women, persons deprived of their liberty, persons under guardianship or trusteeship, persons in an emergency situation
• Person not affiliated to a social security scheme or not entitled to

Sponsors & Collaborators

• Assistance Publique Hopitaux De Marseille: lead

Study Sites (1)

Assistance Publique Des Hopitaux de Marseille

Marseille, PACA, 13354, France

RECRUITING

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration Disorders; Respiratory Tract Diseases

Study Officials

• EMILIE GARRIDO PRADALIE

  APHM

  STUDY DIRECTOR

Central Study Contacts

PHILIPPE GIOVANnETTI

CONTACT

+33 491366141; Philippe.GIOVANNETTI@ap-hm.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 16, 2018
• First Posted: August 17, 2018
• Study Start: May 31, 2018
• Primary Completion: June 1, 2020
• Study Completion: December 1, 2020
• Last Updated: August 17, 2018

Record last verified: 2018-08

Locations

FR (1)